Customized QMS to Navigate GxP Regulated Phases
Explore how we supported a pharmaceutical startup meet regulatory requirements when taking their product from research to development.
GOOD STORIES
In aseptic manufacturing, Environmental Monitoring Process Qualifications (EM PQs) play a critical role in maintaining sterility, ensuring compliance, and safeguarding product integrity. Whether introducing a new facility, scaling production, or revising processes, an effective EM PQ is indispensable. Our team partnered with a leading pharmaceutical production facility to address key challenges and deliver a seamless qualification process.
THE CHALLENGE
Pharmaceutical production environments face numerous hurdles in executing EM PQs effectively. The primary challenges include:
Addressing these challenges required a meticulous approach to ensure compliance and operational efficiency, while safeguarding the integrity of the production process.

OUR APPROACH
We leveraged our extensive experience in delivering seamless and effective EM PQs, leading room and EM PQs for pharmaceutical production facilities.
We conducted thorough risk assessments to identify contamination risks and developed customized validation plans to ensure compliance with stringent regulatory requirements.
We coordinated cross-functional teams (QA, QC, production, and engineering) to ensure smooth execution, completing all EM PQ tests on time and in full compliance with standards.
We managed and evaluated data to meet predefined criteria, addressed deviations through root cause analysis, and implemented corrective actions swiftly. Clear, comprehensive reports were delivered to support regulatory reviews.
We ensured all qualification activities met compliance standards, successfully releasing the facility for GMP production and enabling the timely manufacture of aseptic drug substances.
THE RESULTS
Our collaborative effort led to several key outcomes:
This project exemplifies our commitment to delivering tailored, effective solutions that meet the unique needs of pharmaceutical production facilities, ensuring both compliance and operational excellence.

Explore how we supported a pharmaceutical startup meet regulatory requirements when taking their product from research to development.
Discover how we implemented a new analytical test method to ensure the quality and safe use of a novel drug substance for clinical trial material.
Explore how our systemic approach to API processes yielded close to 100% reduction of API content variation and a reduction of batch scrap rate from 40% to 10%.
Have A Question?
If you have any questions about this case or our Environmental Monitoring services, please get in touch with Britt Dam Raaby.

Britt Dam Raaby
Vice President